METHOHEXITAL SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Methohexital Sodium, and when can generic versions of Methohexital Sodium launch?
Methohexital Sodium is a drug marketed by Steriscience and is included in one NDA.
The generic ingredient in METHOHEXITAL SODIUM is methohexital sodium. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methohexital sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methohexital Sodium
A generic version of METHOHEXITAL SODIUM was approved as methohexital sodium by STERISCIENCE on October 3rd, 2024.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHOHEXITAL SODIUM?
- What are the global sales for METHOHEXITAL SODIUM?
- What is Average Wholesale Price for METHOHEXITAL SODIUM?
Summary for METHOHEXITAL SODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 12 |
| Clinical Trials: | 2 |
| Patent Applications: | 780 |
| DailyMed Link: | METHOHEXITAL SODIUM at DailyMed |
Recent Clinical Trials for METHOHEXITAL SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Utah | Phase 3 |
| Rutgers, The State University of New Jersey | Phase 4 |
Pharmacology for METHOHEXITAL SODIUM
| Drug Class | Barbiturate |
Medical Subject Heading (MeSH) Categories for METHOHEXITAL SODIUM
Anatomical Therapeutic Chemical (ATC) Classes for METHOHEXITAL SODIUM
US Patents and Regulatory Information for METHOHEXITAL SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steriscience | METHOHEXITAL SODIUM | methohexital sodium | INJECTABLE;INJECTION | 215488-001 | Oct 3, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
